AR: acute rejection; BPAR: biopsy proven acute rejection; HDC: hemodynamic compromise; ISHLT: International Society of Heart and Lung Transplantation; MMF: mycophenolate mofetil.
aDefined as BPAR grade ≥ 3A (or any BPAR in A2310), acute rejection associated with hemodynamic compromise, graft loss/retransplant, death, or loss to followup.
b for noninferiority (noninferiority margin 13%); for no-difference test.
cNoninferior to the MMF group (noninferiority margin 13%).
d for noninferiority.
eIncluding one death in a patient who never received everolimus.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.